NCT01739829View on ClinicalTrials.gov

Open-label Investigation of the Safety and Effectiveness of DIABECELL® in Patients With Type 1 Diabetes Mellitus

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Type 1 Diabetes
Interventions
DEVICE

DIABECELL (R)

10,000 IEQ per kg body weight (Total Dose) Administered in two doses: 5,000 IEQ/kg three months apart.

DEVICE

DIABECELL (R)

20,000 IEQ per kg body weight (Total Dose) Administered in two doses: 10,000 IEQ/kg three months apart

Trial Locations (1)

Unknown

Hospital Interzonal General de Agudos Eva Perón, Buenos Aires

All Listed Sponsors
lead

Diatranz Otsuka Limited

INDUSTRY

NCT01739829 - Open-label Investigation of the Safety and Effectiveness of DIABECELL® in Patients With Type 1 Diabetes Mellitus | Biotech Hunter | Biotech Hunter